Treatment Options and Follow-Up among Iraqi Patients with Breast Carcinoma


  •   Nada Alwan

  •   Mena M. Shawkat


Breast cancer ranks the first among the Iraqi population and the leading cause of cancer related female mortality. In addition to the barriers that impede early detection of that cancer other major challenges include the capacity for effective multimodality treatment.

Aim: To review and follow up a sample of Iraqi female patients diagnosed with breast cancer in a main referral center; recording their clinico-pathological characteristics, the offered treatment options and the rate of recurrence.

Material and Methods: This retrospective study analyzed the clinical and pathological characteristics of 230 Iraqi female patients histologically diagnosed with breast carcinoma who had reliable valid data related to their demographic, clinical and tumor pathological status. The studied parameters included the age of the patient, marital status, parity, age at first delivery, occupation, history of lactation and hormonal intake, family history of breast and any other cancer, histological type, tumor grade and clinical stage. Hormone receptors (Estrogen and Progesterone) and HER2 over expression contents of the primary tumors were evaluated immunohistochemically. The offered treatment options included surgery, chemotherapy, radiotherapy, hormonal and biological targeted therapy. The rate of recurrence was evaluated after a follow-up period of three years.

Results: Only 3.5% of the patients were under the age of 30 years while 39.1% were aged 50 years and over. About 84% were married, 11.3% were nulliparous, 24.9% had their first delivery before the age of 20 years and 56.9% were housewives. History of lactation was reported in 60.4%, whereas history of breast cancer was registered in 17.4%. The most common histological type of breast carcinoma was the infiltrative ductal (86.5%), well differentiated carcinomas were diagnosed in only 5.2%. The rates of positive ER, PR and HER2 tumor contents were 68.3%, 65.7% and 29.6% respectively. Overall 8.3%, 4.3%, 39.6% and 7.8% of the patients were diagnosed at stages I, II, III and IV respectively.  Surgery was the primary treatment modality prescribed to the vast majority (96.1%) of the patients; 88.2% of those underwent modified radical mastectomy and only 3.6% had breast conservative surgery. Whereas 91.7% received chemotherapy, radiotherapy, hormonal and biological therapy were applied on 65.7%, 63.5% and 27.4% respectively. Recurrence of breast carcinoma three years following treatment was displayed among 9.7%; displaying significant direct association with the clinical stages of the disease (p<.05).

Conclusions: Breast cancer is still diagnosed at relatively advanced stages at the time of first presentation in Iraq; requesting radical mastectomy. Early detection represents the principal approach to control breast cancer in the near future. Regular long-term follow up through multidisciplinary tumor boards is mandatory to monitor response to therapy and recurrence.

Keywords: Breast Carcinoma, Follow-up, Iraqi Patients, Options, Treatment.


Globocan 2018. World Health Organization. International Agency for Research on Cancer (IARC) Press. Geneva, Switzerland, 2018.

Iraqi Cancer Board (2016). Results of the Iraqi Cancer Registry 2015. Baghdad, Iraqi Cancer Registry Center, Ministry of Health, 2018.

Alwan N. Breast Cancer among Iraqi Women: Preliminary Findings from a Regional Comparative Breast Cancer Research Project. J Glob Oncol. 2016; 2(5): 255–258.

Alwan, N, Kerr D, Al-Okati D, et al. Comparative study on the clinic-pathological profiles of breast cancer among Iraqi and British patients. The Open Public Health Journal. 2018; (11): 177–191.

Alwan NA, Tawfeeq FN, Maallah MH, et al. The Stage of Breast Cancer at the Time of Diagnosis: Correlation with the Clinicopathological Findings among Iraqi Patients. J Neoplasm. 2017; 2 (3):22

Alwan NAS, Tawfeeq FN, Mallah N. Demographic and clinical profiles of female patients diagnosed with breast cancer in Iraq. Journal of Contemporary Medical Sciences, 2019; 5 (1): 14-19.

Alwan NAS. Tumor Characteristics of Female Breast Cancer: Pathological Review of Mastectomy Specimens Belonging to Iraqi Patients. World Journal of Breast Cancer Research, 2018; 1 (1): 1-3.

Alwan NAS, Kerr D. Cancer Control in War-Torn Iraq, The Lancet Oncology, 2018; 19 (3): 291-292

Alwan NAS, Tawfeeq FN. Comparison of Clinico-Pathological Presentations of Triple-Negative versus Triple-Positive and HER2 Iraqi Breast Cancer Patients. Open access Macedonian Journal of Medical Sciences, 2019; 7(21):3534-3539.

Weigelt B, Baehner FL, Reis-Filho JS. The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade. J Pathol. 2010; 220:263–280.

World Health Organization. Strategy for cancer prevention and control in the Eastern Mediterranean Region 2009—2013; World Health Organization. Regional Office for the Eastern Mediterranean, 2010.

Alwan N. Iraqi Initiative of a Regional Comparative Breast Cancer Research Project in the Middle East, Journal of Cancer Biology & Research, 2014; 2 (1): 1016 – 1020.

Alwan NAS, Al-Attar WM, Al Mallah N. Barriers to Baseline Needs for Early Detection of Breast Cancer among Iraqi Female Patients. Iraqi National Journal of Nursing Specialties, 2016; 29 (2): 1-11.

Alwan N, al-Attar W, Eliessa R, Al-Midfaei Z & Nidhal F:” Knowledge, Attitude and Practice regarding Breast Cancer and Breast Self-Examination among a Sample of the Educated Population in Iraq”. EMHJ, WHO, EMRO, 2012; 18 (4): 337-345

Al Alwan NAS and Mualla FHM: Promoting Clinical Breast Examination as a Screening Tool for Breast Cancer in Iraq. Iraqi National Journal for Nursing Specialties, 2014; 27 (1): 76-82.

Al Alwan N: Establishing Guidelines for Early Detection of Breast Cancer in Iraq. Int. J. of Advanced Research. 2015. 3 (12): 539-555

Alwan N, Al-Diwan J, Al-Attar W & Eliessa R: “Knowledge, Attitudes and Practice towards Breast Cancer and BSE in Kirkuk University, Iraq”. Asian Pacific Journal of Reproduction, Elsevier, 2012; 1 (4): 308-311.

Alwan NAS and Al-Attar: Evaluating the Effect of an Educational Teaching Model on the Knowledge about Breast Cancer among Female University Students in Iraq., JJ Cancer Sci. Res. 2016, 2 (1): 026

Alwan NAS, Alattar W, Mallah N, Hassoun T: Baseline Needs Assessment for Breast Cancer Awareness and Management among Paramedical Health Care Providers in Iraq. International Journal of Science and Research (IJSR), 2017; 6 (7):1515-1520.

Alwan NAS, Tawfeeq FN, Abdulsattar SY, Yihya F. Assessing the period between diagnosis of breast cancer and surgical treatment among mastectomized female patients. International Journal of Medical Research & Health Sciences, 2019; 8 (1), 2019.

Von Karsa L, Qiao Y, Ramadas K et al. Prevention/Screening Implementation, in Stewart BW and Wild CP (eds): World Cancer Report 2014. Lyon, France, World Health Organization International Agency for Research on Cancer, 2014

Sankar R, Alwan N, Denny L. How Can We Improve Survival from Breast Cancer in Developing Countries?. Future Medicine, Breast Cancer Management, 2013, 2 (3): 179-183.

El Saghir N, Khalil MK, Eid T, et al. Trends in epidemiology and management of breast cancer in developing Arab countries: A literature and registry analysis. International Journal of Surgery, 2007; 226-233.

Shulman LN, Willett W, Sievers A et al. Breast Cancer in Developing Countries: Opportunities for Improved Survival, Journal of Oncology, 2010; 1-6.

Baccach J, Mansouri M, Derkaoui T et al. Clinicopathologic and prognostic features of breast cancer in young women: a seriesfrom North of Morocco. BMC Women's Health, 2017; 17:106

Lakhani SR, Ellis IO, Schnitt SJ et al. WHO Classification of Tumours of the Breast. Fourth Edition, WHO Classification of Tumours, Volume 4, IARC, 2012.

Elston CW, Ellis IO: Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up. Histopathology, 2002; 41:154-161.

Sobin LH, Gospodarowicz MK, Wittekind C. TNM Classification of Malignant Tumours. New York, NY, John Wiley & Sons 2011.

Alwan NAS: Family History among Iraqi Patents Diagnosed with Breast Cancer, IJSR, 2017; 6 (2): 868-872

Chia KS, Reilly M, Tan CS, et al. Profound changes in breast cancer incidence may reflect changes into a Westernized lifestyle: a comparative population-based study in Singapore and Sweden, Int J Cancer, 2005; 113 (2): 302-306)

Eleni L, Demetri Ss, Bernard al. Effects of Reproductive and Demographic Changes on Breast Cancer Incidence in China: A Modeling Analysis, JNCI: Journal of the National Cancer Institute, 2008; 100 (19):1352–1360.

Momenimovahed Z, Salehiniya H. Epidemiological characteristics of and risk factors for breast cancer in the world. Breast Cancer, 2019; 11:151–164.

Erica T. Warner, Rulla M. Tamimi, Melissa E et al. Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors. Journal of Clinical Oncology, 2015; 33 (20): 2254-2261

Min Yi, Peijun Liu, Xu Li et al. Comparative Analysis of Clinicopathologic Features, Treatment, and Survival of Asian Women with a Breast Cancer Diagnosis Residing in the United States. Cancer, 2012: 1: 4117-4125.

Alwan NAS: Clinical and Pathological Characteristics of Familial Breast Cancer in Iraq, Chronicle Journal of Cancer Science, 2017; 1 (1): 002

Alwan NAS, Mualla F, Naqash M et al: Clinical and Pathological Characteristics of Triple Positive Breast Cancer among Iraqi Patients, Gulf Journal of Oncology, 2017; 25: 6-15.

Alwan NAS, Tawfeeq FN, Muallah FH. Breast Cancer Subtypes among Iraqi Patients: Identified by Their ER, PR and HER2 Status. J Fac Med Baghdad, 2017; 59 (4): 304-307.

Espina C, McKenzie F, Siva I. Delayed presentation and diagnosis of breast cancer in African women: a systematic review. Annals of Epidemiology, 2017; 27: 659-671.

Talpur AA, Surahio AR, Ansari A. Late presentation of breast cancer: A Dilemma. J. Pak Med Assoc. 2011; 61 (7): 661-666.

Echavarria MI, Anderson BO, Duggan C, Thompson B. Global uptake of BHGI guidelines for breast cancer. The Lancet Oncology, 2014; 15 (13): 1421-1423.

Lazaraviciute G, Chaturvedi S. Mastectomy—A Critical Review. Open Journal of Clinical Diagnostics, 2017; 7: 58-66.

Powell E, Joanne Chafe RN MN. Surgical treatment choices for breast cancer in Newfoundland and Labrador: a retrospective cohort study. Canadian Journal of Surgery. 2018; 1; 61(6):377.

Onitilo, A.A., Engel, J.M., Stankowski, R.V. et al. Survival Comparisons for Breast Conserving Surgery and Mastectomy Revisited: Community Experience and the Role of Radiation Therapy. Clinical Medicine & Research, 2015; 13: 65-73.

Anthony FY, Yadav NU, Lung BY et al. Trastuzumab interruption and treatment-induced cardiotoxicity in early HER2-positive breast cancer. Breast Cancer Research and Treatment. 2015 Jan 1; 149 (2):489-95.

Carlson RW, Anderson BO, Chopra R et al. Treatment of Breast Cancer in Countries with Limited Resources. The Breast Journal, 2003; 9 (2): 567-574.

Freedman GM, Fowble BL. Local Recurrence after Mastectomy or Breast-Conserving Surgery and Radiation. Oncology, 2000; 14 (11): 1561-1581.

Lafourcade A, His M, Baglietto L et al. Factors associated with breast cancer recurrences or mortality and dynamic prediction of death using history of cancer recurrences. BMC cancer. 2018; 18 (1):171.

Soerjomataram I, Louwman MW, Ribot JG et al. An overview of prognostic factors for long-term survivors of breast cancer. Breast Cancer Research and Treatment. 2008; 107 (3):309-30.

Love RR: Defining a global research agenda for breast cancer. Cancer. 2008; 113: 2366-2371.


Download data is not yet available.


How to Cite
Alwan, N., & Shawkat, M. (2020). Treatment Options and Follow-Up among Iraqi Patients with Breast Carcinoma. European Journal of Medical and Health Sciences, 2(2).